Bluebook
Diagnostics and Tools January 2024
2024 - January: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Sofie Biosciences, Inc. (25.8% stake) was acquired by Trilantic Capital Management L.P.
- Roche Diagnostics Corporation announced its acquisition of LumiraDx Point-of-Care Testing Tech
- Elephas Biosciences Corporation closed a $55MM Series A Financing, led by Arch Venture Partners, L.P., State of Wisconsin Investment Board, Venture Investors, LLC, Sands Capital Management, LLC, Tao Capital Partners, Northpond Ventures, LLC, dRx Capital AG, WARF Ventures